Tumors and the danger model

Acta Biochimica Polonica

Volumn 49, Issue 2, 2002, Pages 295-302

  Kowalczyk, Dariusz W ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cancer; Danger signal; Dendritic cells

Indexed keywords

TUMOR ANTIGEN;

ANIMAL; BIOLOGICAL MODEL; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; NEOPLASM; PATHOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, NEOPLASM; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; MODELS, BIOLOGICAL; NEOPLASMS; T-LYMPHOCYTES;

EID: 0038890309     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2002_3787     Document Type: Review

References (26)

1. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science.; 274: 94-6.
2. Basu S, Binder RJ, Ramalingam T, Srivastava PK. (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity.; 14: 303-13.
3. Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA, Banchereau J. (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med.; 190: 1417-26.
4. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature.; 393: 478-80.
5. Binder RJ, Han DK, Srivastava PK. (2000) CD91: a receptor for heat shock protein gp96. Nat Immunol.; 1: 151-5.
6. Fields PA, Kowalczyk DW, Arruda VR, Armstrong E, McCleland ML, Hagstrom JN, Pasi KJ, Ertl HC, Herzog RW, High KA. (2000) Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Mol Ther.; 1: 225-35.
7. Fuchs EJ, Matzinger P. (1992) B cells turn off virgin but not memory T cells. Science.; 258: 1156-9.
8. Fuchs EJ, Matzinger P. (1996) Is cancer dangerous to the immune system? Semin Immunol.; 8:271-80.
9. Galluci S, Matzinger P. (2001) Danger signals: SOS to the immune system. Curr Opin Immunol.; 13: 114-9.
10. He Z, Wlazlo AP, Kowalczyk DW, Cheng J, Xiang ZQ, Giles-Davis W, Ertl HC. (2000) Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology.; 270: 146-61.
11. Janeway Jr CA. (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today.; 13: 11-6.
12. Jooss K, Yang Y, Fisher KJ, Wilson JM. (1998) Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol.; 72: 4212-23.
13. Kowalczyk DW, Ertl HC. (1999) Immune responses to DNA vaccines. Cell Mol Life Sci.; 55: 751-70.
14. Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, Ertl HC. (2001) A method that allows easy characterization of tumor-infiltrating lymphocytes. J Immunol Methods.; 253: 163-75.
15. Kowalczyk DW, Wlazlo AP, Giles-Davis W, Ertl HC. (2000) Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells. J Immunol Methods.; 241: 131-9.
16. Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, Lowy DR, Schiller JT. (2001) Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol; 166: 5346-55.
17. Matzinger P. (1994) Tolerance, danger, and the extended family. Annu Rev Immunol.; 12: 991-1045.
18. Matzinger P. (1998) An innate sense of danger. Semin Immunol.; 10: 399-415.
19. Ridge JP, Di Rosa F, Matzinger P. (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature.; 393: 474-8
20. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. (1998) T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature.; 393: 480-3.
21. Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, Pardoll D, Levitsky H. (1998) Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci U S A.; 95: 1178-83.
22. Suto R, Srivastava PK. (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science.; 269: 1585-8.
23. Udono H, Levey DL, Srivastava PK. (1994) Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CDS+ T cells in vivo. Proc Natl Acad Sci U S A.; 91: 3077-81.
24. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science.; 259: 1745-9.
25. + T cell responses. Curr Biol.; 4: 499-505.
26. Xiang ZQ, Yang Y, Wilson JM, Ertl HC. (1996) A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology.; 219: 220-7.